Incidence of elevated procalcitonin and presepsin levels after severe trauma: a pilot cohort study

被引:26
作者
Hoshino, K. [1 ]
Irie, Y. [1 ]
Mizunuma, M. [1 ]
Kawano, K. [1 ]
Kitamura, T. [1 ]
Ishikura, H. [1 ]
机构
[1] Fukuoka Univ, Dept Emergency & Crit Care Med, Fac Med, Fukuoka, Japan
关键词
Injury Severity Score; packed red blood cell; sepsis biomarker; transfusion; CRITICALLY-ILL PATIENTS; BACTERIAL-INFECTION; SERUM PROCALCITONIN; SEPSIS; DIAGNOSIS; INJURY; INFLAMMATION; BIOMARKERS; CALCITONIN; UTILITY;
D O I
10.1177/0310057X1704500510
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Procalcitonin (PCT) and presepsin (PSEP) are useful biomarkers for diagnosing sepsis; however, elevated PCT and PSEP levels may be observed in conditions other than sepsis. We hypothesised that PCT and PSEP levels could increase after severe traumatic injuries. Trauma patients with an Injury Severity Score of >= 16 from October 2013 to September 2015 were enrolled in our study. We examined PCT and PSEP levels and their positive rates on days 0 and 1. PCT and PSEP levels on days 0 and 1 were compared. Risk factors for increasing sepsis biomarker levels were identified by multivariate logistic regression analyses. In this study, 75 patients were included. PCT levels on days 0 and 1 were 0.1+/-0.4 and 1.8+/-6.3 ng/ml, respectively (P=0.02). PSEP levels on days 0 and 1 were 221 261 and 222 207 pg/ml, respectively (P=0.98). As per multivariate logistic regression analyses, packed red blood cell (PRBC) transfusion was the only independent risk factor for higher PCT levels on day 1 (P=0.04). Using PCT to diagnose sepsis in trauma patients on day 1 requires caution. PRBC transfusion was found to be a risk factor for increasing PCT levels. On the other hand, PSEP levels were not affected by trauma during the early phases.
引用
收藏
页码:600 / 604
页数:5
相关论文
共 27 条
[1]
Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9
[2]
EPIDEMIOLOGY OF TRAUMA DEATHS [J].
BAKER, CC ;
OPPENHEIMER, L ;
STEPHENS, B ;
LEWIS, FR ;
TRUNKEY, DD .
AMERICAN JOURNAL OF SURGERY, 1980, 140 (01) :144-150
[3]
STRATEGIES FOR THE AVOIDANCE OF BACTERIAL-CONTAMINATION OF BLOOD COMPONENTS [J].
BARRETT, BB ;
ANDERSEN, JW ;
ANDERSON, KC .
TRANSFUSION, 1993, 33 (03) :228-233
[4]
Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations [J].
Becker, Kenneth L. ;
Snider, Richard ;
Nylen, Eric S. .
CRITICAL CARE MEDICINE, 2008, 36 (03) :941-952
[5]
Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors [J].
Becker, KL ;
Nylén, ES ;
White, JC ;
Müller, B ;
Snider, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1512-1525
[6]
Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma [J].
Castelli, Gian Paolo ;
Pognani, Claudio ;
Cita, Massimo ;
Paladini, Rolando .
CRITICAL CARE MEDICINE, 2009, 37 (06) :1845-1849
[7]
Christ-Crain M, 2005, SWISS MED WKLY, V135, P451
[8]
Biomarkers predicting sepsis in polytrauma patients: Current evidence [J].
Ciriello, Vincenzo ;
Gudipati, Suribabu ;
Stavrou, Petros Z. ;
Kanakaris, Nikolaos K. ;
Bellamy, Mark C. ;
Giannoudis, Peter V. .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2013, 44 (12) :1680-1692
[9]
Procalcitonin as a Marker of Severe Bacterial Infection in Children in the Emergency Department [J].
Deis, Jamie N. ;
Creech, Clarence B. ;
Estrada, Cristina M. ;
Abramo, Thomas J. .
PEDIATRIC EMERGENCY CARE, 2010, 26 (01) :51-63
[10]
Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? [J].
Delèvaux, I ;
André, M ;
Colombier, M ;
Albuisson, E ;
Meylheuc, F ;
Bègue, RJ ;
Piette, JC ;
Aumaître, O .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) :337-340